Liver hydatidosis, a parasitic endemic disease affecting extensive areas in our planet, has been for decades a topic of debate in multiple medical and surgical forums because of its incidence, nonspecific symptoms, and diagnostic modalities, as well as the surgical procedures devised to solve this condition.
Medical treatment with antiparasitic drugs (albendazole or derivatives), while initially endorsed with substantial interest has provided no significant benefits, and potential serious complications (liver toxicity, bone marrow aplasia, etc.) greatly restrict its use (8) (9) (10) .
Similarly, the fact should be borne in mind that serious complications secondary to chronic, prolonged hydatidosis have emerged in recent years, including secondary biliary cirrhosis, secondary biliary sclerosis, cholangitis, Budd-Chiari syndrome, and postnecrotic cirrhosis, which have subsequently needed wide resective surgery or even a liver transplant (11) .
What is the role of laparoscopic surgery in the management of hydatidosis? It was initially highly promising but expectations set in early reports could not be corroborated afterwards (12) (13) (14) (15) . On the other hand, conservative surgery or PAIR (Puncture, Aspiration, Instillation, Re-aspiration) has not improved outcomes, and morbidity and mortality remain similar to those reported during the 1980s (16) (17) (18) .
Our crucial question should be "Which therapy would be most appropriate and effective for liver hydatidosis in the upcoming decades?
Our answer is straightforward in reference to countries where modern, advanced medicine is practised, and where specific issues are treated by expert groups obtaining outstanding benefits. To this day surgery is the most effective treatment, and radical surgery (total cystectomy, hepatectomy) is the modality yielding the best results (19) .
Regarding liver diseases, a high number of hospitals have medico-surgical hepatology units that satisfactorily solve conditions such as chronic hepatitis, liver tumors, etc., using surgical approaches where huge liver resection (hepatectomy, trisegmentectomy, etc.) entails no or little morbidity and mortality (20, 21) based not only on refined surgical techniques but also diagnostic tests (volume CT, MRI, angiography, etc.) that allow thorough knowledge regarding lesion size, location, and relations to intrahepatic vascular and biliary structures, as well as liver function. The above leads to a significant decrease in postoperative morbidity, as evidenced by a number of scientific papers (20) (21) (22) . The clearest example of reduced morbidity in liver surgery is living-donor liver transplantation, where a liver portion (usually from a relative) is transplanted to a receiver. Donor hepatectomy entails no secondary problems in most cases.
If we translate these data into liver hydatidosis, an obvious question emerges: "What barriers prevent this condition from being managed in liver units?
There is logically no contraindication except in patients with other concomitant diseases rendering wide resective surgery a contraindication (22) .
Conservative surgery (partial cystectomy, puncture aspiration, PAIR, etc.) retain a substantial morbidity, which is reflected not only by worse outcomes with higher relapse rates, but also by long-term complications that may jeopardize patient quality of life.
Therefore, in our view a patient with liver hydatidosis should be studied using the appropriate tests to reach an accurate diagnosis in terms of size, location, etc., allowing insight into the liver's functional capacity (ultrasounds, CT, MRI), and then undergo radical surgery, if possible by an expert team.
To conclude, it should be remembered that this proposal must be supported not only with medical aspects but also from an ethical standpoint, and perhaps the criminal liability often involved in current medicine.
